Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity

PR Newswire
March 8, 2024 — 23:24 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: computer investment pharmaceutical

Related News:

APAC Hiring Intentions Strengthen as Employers Express Optimism for Q2 2025

March 11, 2025 — 00:01

Starlab Advances to Full Development After Successfully Completing Key NASA Milestone

March 4, 2025 — 05:16

Trip.com Group champions further recovery and long-term growth for ASEAN tourism

January 27, 2025 — 15:43

Altair Engineering Inc. Stockholders Approve Proposed Merger with Siemens

January 23, 2025 — 05:05

Supermicro Begins Volume Shipments of Max-Performance Servers Optimized for AI, HPC, Virtualization, and Edge Workloads

January 9, 2025 — 22:05

MANTRA and DAMAC Group Revolutionize Tokenized Real-World Assets with US$1 Billion Deal

January 9, 2025 — 22:00

Evolving Global Asset Management Industry in Focus at Asset Abu Dhabi

December 11, 2024 — 02:10

LPS Launches NeuroNode: Empowering Advanced AI for Enterprises with On-Premises LLM

November 7, 2024 — 17:39

Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation

September 14, 2024 — 08:18

Franchising and Licensing Asia (FLAsia) 2024